{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:35:30Z","timestamp":1790642130483,"version":"4.1.0"},"reference-count":112,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Painful diabetic neuropathy (PDN) is a common complication of diabetes mellitus that is associated with a significant decline in quality of life. Like other painful neuropathic conditions, PDN is difficult to manage clinically, and a variety of pharmacological and non-pharmacological options are available for this condition. Recommended pharmacotherapies include anticonvulsive agents, antidepressant drugs, and topical capsaicin; and tapentadol, which combines opioid agonism and norepinephrine reuptake inhibition, has also recently been approved for use. Additionally, several neuromodulation therapies have been successfully used for pain relief in PDN, including intrathecal therapy, transcutaneous electrical nerve stimulation (TENS), and spinal cord stimulation (SCS). Recently, 10 kHz SCS has been shown to provide clinically meaningful pain relief for patients refractory to conventional medical management, with a subset of patients demonstrating improvement in neurological function. This literature review is intended to discuss the dosage and prospective data associated with pain management therapies for PDN.<\/jats:p>","DOI":"10.3390\/biomedicines9050573","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T12:58:07Z","timestamp":1621429087000},"page":"573","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Treatment of Painful Diabetic Neuropathy\u2014A Narrative Review of Pharmacological and Interventional Approaches"],"prefix":"10.3390","volume":"9","author":[{"given":"Mayank","family":"Gupta","sequence":"first","affiliation":[{"name":"Kansas Pain Management &amp; Neuroscience Research Center, Overland Park, KS 66201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8028-1495","authenticated-orcid":false,"given":"Nebojsa Nick","family":"Knezevic","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Advocate Illinois Masonic Medical Center, Chicago, IL 60657, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Abd-Elsayed","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53715, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahoua","family":"Ray","sequence":"additional","affiliation":[{"name":"Kansas Pain Management &amp; Neuroscience Research Center, Overland Park, KS 66201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pain Management, Spine and Pain Institute of New York, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavika","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Saint Luke\u2019s South Hospital, Overland Park, KS 66213, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"key":"ref_1","unstructured":"Centers for Disease Control and Prevention (2020). National Diabetes Statistics Report, 2020, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services."},{"key":"ref_2","unstructured":"World Health Organization (2016). Global Report on Diabetes, World Health Organization."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic Neuropathy: A Position Statement by the American Diabetes Association","volume":"40","author":"Boulton","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.2337\/diacare.26.6.1790","article-title":"The health care costs of diabetic peripheral neuropathy in the US","volume":"26","author":"Gordois","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00002508-200211000-00002","article-title":"Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy","volume":"18","author":"Schmader","year":"2002","journal-title":"Clin. J. Pain"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/1056-8727(92)90049-Q","article-title":"The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group","volume":"6","author":"Ziegler","year":"1992","journal-title":"J. Diabetes Complicat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2337\/diacare.16.8.1187","article-title":"Painful neuropathy and foot ulceration in diabetic patients","volume":"16","author":"Veves","year":"1993","journal-title":"Diabetes Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-8227(99)00112-6","article-title":"Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life","volume":"47","author":"Galer","year":"2000","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Deng, Y., Luo, L., Hu, Y., Fang, K., and Liu, J. (2016). Clinical practice guidelines for the management of neuropathic pain: A systematic review. BMC Anesthesiol., 16.","DOI":"10.1186\/s12871-015-0150-5"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","article-title":"Diabetic neuropathy: Clinical manifestations and current treatments","volume":"11","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11910-014-0473-5","article-title":"Diabetic neuropathy: Mechanisms, emerging treatments, and subtypes","volume":"14","author":"Albers","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_12","unstructured":"Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., de Herder, W.W., Dungan, K., Grossman, A., Hershman, J.M., Hofland, H.J., and Kaltsas, G. (2000). Diabetic Neuropathies. Endotext, MDText.com, Inc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1464-5491.2004.01271.x","article-title":"Chronic painful peripheral neuropathy in an urban community: A controlled comparison of people with and without diabetes","volume":"21","author":"Daousi","year":"2004","journal-title":"Diabet. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5214\/ans.0972.7531.1118409","article-title":"Painful diabetic neuropathy: An update","volume":"18","author":"Kaur","year":"2011","journal-title":"Ann. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00296-016-3481-8","article-title":"An overview of treatment approaches for chronic pain management","volume":"37","author":"Duarte","year":"2017","journal-title":"Rheumatol. Int."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Staudt, M.D., Prabhala, T., Sheldon, B.L., Quaranta, N., Zakher, M., Bhullar, R., Pilitsis, J.G., and Argoff, C.E. (2020). Current Strategies for the Management of Painful Diabetic Neuropathy. J. Diabetes Sci. Technol.","DOI":"10.1177\/1932296820951829"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2021). 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2021. Diabetes Care, 44, S151\u2013S167.","DOI":"10.2337\/dc21-S011"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","article-title":"Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"76","author":"Bril","year":"2011","journal-title":"Neurology"},{"key":"ref_20","first-page":"227","article-title":"Treating Painful Diabetic Peripheral Neuropathy: An Update","volume":"94","author":"Snyder","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"ref_21","first-page":"151","article-title":"Treating diabetic peripheral neuropathic pain","volume":"82","author":"Lindsay","year":"2010","journal-title":"Am. Fam. Physician"},{"key":"ref_22","unstructured":"Vinik, A., Casellini, C., and Nevoret, M.L. (2000). Diabetic Neuropathies, Endotext [Internet]. Last Updated, 2018."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1525-1403.2006.00050.x","article-title":"Factors affecting impedance of percutaneous leads in spinal cord stimulation","volume":"9","author":"Alo","year":"2006","journal-title":"Neuromodulation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1093\/pm\/pnz075","article-title":"A Comprehensive Algorithm for Management of Neuropathic Pain","volume":"20","author":"Bates","year":"2019","journal-title":"Pain Med."},{"key":"ref_25","unstructured":"Cross, A.L., Viswanath, O., and Sherman, A. (2020). Pregabalin. StatPearls, StatPearls Publishing."},{"key":"ref_26","unstructured":"Yasaei, R., Katta, S., and Saadabadi, A. (2020). Gabapentin. StatPearls, StatPearls Publishing."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/00006123-200204000-00003","article-title":"New trends in neuromodulation for the management of neuropathic pain","volume":"50","author":"Alo","year":"2002","journal-title":"Neurosurgery"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1528-1157.1999.tb00934.x","article-title":"Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: A multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus","volume":"40","author":"Backonja","year":"1999","journal-title":"Epilepsia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1526-4637.2005.00061.x","article-title":"A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain","volume":"6","author":"Raskin","year":"2005","journal-title":"Pain Med."},{"key":"ref_31","unstructured":"International Neuromodulation Society (2021, February 06). Neuromodulation: An Emerging Field. Available online: https:\/\/www.neuromodulation.com\/medical-therapy-overview."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2337\/dc10-1793","article-title":"A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: A randomized, double-blind, cross-over clinical trial","volume":"34","author":"Kaur","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_34","first-page":"E705","article-title":"Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: A network meta-analysis","volume":"16","author":"Rudroju","year":"2013","journal-title":"Pain Physician"},{"key":"ref_35","first-page":"CD007938","article-title":"Gabapentin for chronic neuropathic pain in adults","volume":"6","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_36","unstructured":"Dhaliwal, J.S., Spurling, B.C., and Molla, M. (2020). Duloxetine. StatPearls, StatPearls Publishing."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2016.06.057","article-title":"Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights","volume":"338","author":"Kremer","year":"2016","journal-title":"Neuroscience"},{"key":"ref_38","unstructured":"Moraczewski, J., and Aedma, K.K. (2020). Tricyclic Antidepressants. StatPearls, StatPearls Publishing."},{"key":"ref_39","first-page":"833","article-title":"Review of duloxetine in the management of diabetic peripheral neuropathic pain","volume":"3","author":"Smith","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","article-title":"Duloxetine vs. placebo in patients with painful diabetic neuropathy","volume":"116","author":"Goldstein","year":"2005","journal-title":"Pain"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pain.2004.05.010","article-title":"Venlafaxine extended release in the treatment of painful diabetic neuropathy: A double-blind, placebo-controlled study","volume":"110","author":"Rowbotham","year":"2004","journal-title":"Pain"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2018.18472","article-title":"Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis","volume":"320","author":"Busse","year":"2018","journal-title":"JAMA"},{"key":"ref_43","first-page":"CD011669","article-title":"Morphine for chronic neuropathic pain in adults","volume":"5","author":"Cooper","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s10072-020-04435-0","article-title":"Improving care of chronic pain patients with spinal cord stimulator therapy amidst the opioid epidemic","volume":"41","author":"Gupta","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2147\/JPR.S190162","article-title":"Tapentadol for neuropathic pain: A review of clinical studies","volume":"12","author":"Freo","year":"2019","journal-title":"J. Pain Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2040622314552071","article-title":"Treatment of painful diabetic neuropathy","volume":"6","author":"Javed","year":"2015","journal-title":"Ther. Adv. Chronic. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1185\/03007995.2010.537589","article-title":"Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: Results of a randomized-withdrawal, placebo-controlled trial","volume":"27","author":"Schwartz","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.2337\/dc13-2291","article-title":"A randomized withdrawal, placebo-controlled study evaluating the efficacy and tolerability of tapentadol extended release in patients with chronic painful diabetic peripheral neuropathy","volume":"37","author":"Vinik","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1067\/mob.2002.130004","article-title":"Sacral neuromodulation in an older, urge-incontinent population","volume":"187","author":"Amundsen","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jpain.2016.09.008","article-title":"Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study","volume":"18","author":"Simpson","year":"2017","journal-title":"J. Pain"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s00125-005-1728-0","article-title":"Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation","volume":"48","author":"Reichstein","year":"2005","journal-title":"Diabetologia"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.apmr.2009.01.019","article-title":"Pulsed electromagnetic fields to reduce diabetic neuropathic pain and stimulate neuronal repair: A randomized controlled trial","volume":"90","author":"Weintraub","year":"2009","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00125-012-2795-7","article-title":"Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: Results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial","volume":"56","author":"Bosi","year":"2013","journal-title":"Diabetologia"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-1403.2006.00055.x","article-title":"Intrathecal ziconotide in the treatment of chronic nonmalignant pain: A randomized, double-blind, placebo-controlled clinical trial","volume":"9","author":"Wallace","year":"2006","journal-title":"Neuromodulation"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(96)02467-1","article-title":"Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy","volume":"348","author":"Tesfaye","year":"1996","journal-title":"Lancet"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jdiacomp.2007.08.002","article-title":"Effect and safety of spinal cord stimulation for treatment of chronic pain caused by diabetic neuropathy","volume":"23","author":"Rajan","year":"2009","journal-title":"J. Diabetes Complicat."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/bja\/aes251","article-title":"Pain relief and quality-of-life improvement after spinal cord stimulation in painful diabetic polyneuropathy: A pilot study","volume":"109","author":"Pluijms","year":"2012","journal-title":"Br. J. Anaesth."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.2337\/dc14-0684","article-title":"Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: A prospective two-center randomized controlled trial","volume":"37","author":"Slangen","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.2337\/dc15-0740","article-title":"Sustained Treatment Effect of Spinal Cord Stimulation in Painful Diabetic Peripheral Neuropathy: 24-Month Follow-up of a Prospective Two-Center Randomized Controlled Trial","volume":"38","author":"Slangen","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/dc17-0983","article-title":"Severity of Neuropathy Is Associated With Long-term Spinal Cord Stimulation Outcome in Painful Diabetic Peripheral Neuropathy: Five-Year Follow-up of a Prospective Two-Center Clinical Trial","volume":"41","author":"Geurts","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.pain.2014.08.031","article-title":"Spinal cord stimulation in patients with painful diabetic neuropathy: A multicentre randomized clinical trial","volume":"155","author":"Meier","year":"2014","journal-title":"Pain"},{"key":"ref_62","unstructured":"Galan, V., Scowcroft, J., Chang, P., Li, S., Staats, P., and Subbaroyan, J. (2020, January 23\u201326). 10 kHz Spinal Cord Stimulation (SCS) for the Treatment of Chronic Peripheral Polyneuropathy (PPN): 12-month Results from Prospective Study. Proceedings of the 2020 North American Neuromodulation Society Annual Meeting, Las Vegas, NV, USA."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2217\/pmt-2020-0033","article-title":"10-kHz spinal cord stimulation treatment for painful diabetic neuropathy: Results from post-hoc analysis of the SENZA-PPN study","volume":"10","author":"Galan","year":"2020","journal-title":"Pain Manag."},{"key":"ref_64","unstructured":"Petersen, E., Stauss, T., Scowcroft, J., Brooks, E., White, J., Sills, S., Amirdelfan, K., Guirguis, M., Xu, J., and Yu, C. (2021, January 14\u201317). Sustained Benefits of 10 kHz Spinal Cord Stimulation for Painful Diabetic Neuropathy: 6-Month Randomized Controlled Trial Results. Proceedings of the 2021 North American Neuromodulation Society Virtual Meeting."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Petersen, E.A., Stauss, T.G., Scowcroft, J.A., Brooks, E.S., White, J.L., Sills, S.M., Amirdelfan, K., Guirguis, M.N., Xu, J., and Yu, C. (2021). Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical Trial. JAMA Neurol.","DOI":"10.1016\/j.diabres.2022.109673"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1054\/jpai.2003.434","article-title":"Transcutaneous electrical nerve stimulation: Basic science mechanisms and clinical effectiveness","volume":"4","author":"Sluka","year":"2003","journal-title":"J. Pain"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1177\/193229681300700510","article-title":"Electrical stimulation as an adjunctive treatment of painful and sensory diabetic neuropathy","volume":"7","author":"Thakral","year":"2013","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_68","unstructured":"Teoli, D., and An, J. (2020). Transcutaneous Electrical Nerve Stimulation. StatPearls, StatPearls Publishing."},{"key":"ref_69","first-page":"CD011976","article-title":"Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults","volume":"9","author":"Gibson","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2337\/diacare.21.8.1322","article-title":"Diabetic peripheral neuropathy. Effectiveness of electrotherapy and amitriptyline for symptomatic relief","volume":"21","author":"Kumar","year":"1998","journal-title":"Diabetes Care"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2337\/diacare.20.11.1702","article-title":"Diabetic peripheral neuropathy: Amelioration of pain with transcutaneous electrostimulation","volume":"20","author":"Kumar","year":"1997","journal-title":"Diabetes Care"},{"key":"ref_72","unstructured":"Shah, N., and Padalia, D. (2020). Intrathecal Delivery System. StatPearls, StatPearls Publishing."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/brain\/112.1.147","article-title":"Changes in excitability of human cutaneous afferents following prolonged high-frequency stimulation","volume":"112","author":"Applegate","year":"1989","journal-title":"Brain"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ejp.692","article-title":"Cervical 10 kHz spinal cord stimulation in the management of chronic, medically refractory migraine: A prospective, open-label, exploratory study","volume":"20","author":"Arcioni","year":"2016","journal-title":"Eur. J. Pain"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ner.12538","article-title":"The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines","volume":"20","author":"Deer","year":"2017","journal-title":"Neuromodulation"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/pm\/pny132","article-title":"Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options","volume":"20","author":"Deer","year":"2019","journal-title":"Pain Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Raphael, J.H., Duarte, R.V., Southall, J.L., Nightingale, P., and Kitas, G.D. (2013). Randomised, double-blind controlled trial by dose reduction of implanted intrathecal morphine delivery in chronic non-cancer pain. BMJ Open, 3.","DOI":"10.1136\/bmjopen-2013-003061"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1213\/00000539-196707000-00025","article-title":"Electrical inhibition of pain by stimulation of the dorsal columns: Preliminary clinical report","volume":"46","author":"Shealy","year":"1967","journal-title":"Anesth. Analg."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2147\/JPR.S37589","article-title":"Spinal cord stimulation for neuropathic pain: Current perspectives","volume":"7","author":"Wolter","year":"2014","journal-title":"J. Pain Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/pme.12617","article-title":"10-kHz High-Frequency SCS Therapy: A Clinical Summary","volume":"16","author":"Russo","year":"2015","journal-title":"Pain Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.150.3699.971","article-title":"Pain mechanisms: A new theory","volume":"150","author":"Melzack","year":"1965","journal-title":"Science"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/j.1532-2149.2013.00443.x","article-title":"Comparison of intensity-dependent inhibition of spinal wide-dynamic range neurons by dorsal column and peripheral nerve stimulation in a rat model of neuropathic pain","volume":"18","author":"Yang","year":"2014","journal-title":"Eur. J. Pain"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/00325481.2020.1769393","article-title":"Mechanisms and mode of action of spinal cord stimulation in chronic neuropathic pain","volume":"132","author":"Heijmans","year":"2020","journal-title":"Postgrad. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1464-5491.2004.01410.x","article-title":"Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy","volume":"22","author":"Daousi","year":"2005","journal-title":"Diabet. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/ner.12312","article-title":"Treatment-Limiting Complications of Percutaneous Spinal Cord Stimulator Implants: A Review of Eight Years of Experience From an Academic Center Database","volume":"18","author":"Hayek","year":"2015","journal-title":"Neuromodulation"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1093\/pm\/pnz074","article-title":"The Evolution of Neuromodulation in the Treatment of Chronic Pain: Forward-Looking Perspectives","volume":"20","author":"Fishman","year":"2019","journal-title":"Pain Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/ner.12116","article-title":"Burst spinal cord stimulation evaluated in patients with failed back surgery syndrome and painful diabetic neuropathy","volume":"17","author":"Bom","year":"2014","journal-title":"Neuromodulation"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13063-019-4007-y","article-title":"High-frequency spinal cord stimulation at 10 kHz for the treatment of painful diabetic neuropathy: Design of a multicenter, randomized controlled trial (SENZA-PDN)","volume":"21","author":"Mekhail","year":"2020","journal-title":"Trials"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/ner.12698","article-title":"Success Using Neuromodulation With BURST (SUNBURST) Study: Results From a Prospective, Randomized Controlled Trial Using a Novel Burst Waveform","volume":"21","author":"Deer","year":"2018","journal-title":"Neuromodulation"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/papr.12831","article-title":"Burst and Tonic Spinal Cord Stimulation Both Activate Spinal GABAergic Mechanisms to Attenuate Pain in a Rat Model of Chronic Neuropathic Pain","volume":"20","author":"Meuwissen","year":"2020","journal-title":"Pain Pract."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6639801","DOI":"10.1155\/2021\/6639801","article-title":"A Retrospective Review of Lead Migration Rate in Patients Permanently Implanted with Percutaneous Leads and a 10 kHz SCS Device","volume":"2021","author":"Gupta","year":"2021","journal-title":"Pain Res. Manag."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2217\/pmt-2020-0074","article-title":"Pain relief and opioid usage in upper limb and neck pain patients after 10-kHz spinal cord stimulation treatment: Subanalysis of USA studies","volume":"11","author":"Amirdelfan","year":"2021","journal-title":"Pain Manag."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/acn3.720","article-title":"A multicenter real-world review of 10 kHz SCS outcomes for treatment of chronic trunk and\/or limb pain","volume":"6","author":"Stauss","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/nyas.14236","article-title":"Opioid-sparing effects of 10 kHz spinal cord stimulation: A review of clinical evidence","volume":"1462","author":"Amirdelfan","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cns.13285","article-title":"Pain relief and improvement in quality of life with 10 kHz SCS therapy: Summary of clinical evidence","volume":"26","author":"Sayed","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/papr.12932","article-title":"A Prospective, Multi-Center, Clinical Trial of a 10-kHz Spinal Cord Stimulation System in the Treatment of Chronic Pelvic Pain","volume":"21","author":"Tate","year":"2021","journal-title":"Pain Pract."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.2147\/JPR.S278661","article-title":"Ten kilohertz SCS for Treatment of Chronic Upper Extremity Pain (UEP): Results from Prospective Observational Study","volume":"13","author":"Burgher","year":"2020","journal-title":"J. Pain Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuroscience.2019.12.031","article-title":"Low-intensity, Kilohertz Frequency Spinal Cord Stimulation Differently Affects Excitatory and Inhibitory Neurons in the Rodent Superficial Dorsal Horn","volume":"428","author":"Lee","year":"2020","journal-title":"Neuroscience"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"134763","DOI":"10.1016\/j.neulet.2020.134763","article-title":"Early high-frequency spinal cord stimulation treatment inhibited the activation of spinal mitogen-activated protein kinases and ameliorated spared nerve injury-induced neuropathic pain in rats","volume":"721","author":"Liao","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Zannou, A.L., Khadka, N., FallahRad, M., Truong, D.Q., Kopell, B.H., and Bikson, M. (2019). Tissue Temperature Increases by a 10 kHz Spinal Cord Stimulation System: Phantom and Bioheat Model. Neuromodulation.","DOI":"10.1016\/j.brs.2018.12.037"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/ner.13078","article-title":"Response to: \u201cTissue Temperature Increases by a 10 kHz Spinal Cord Stimulation System: Phantom and Bioheat Model\u201d","volume":"22","author":"Caraway","year":"2019","journal-title":"Neuromodulation"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/ner.13079","article-title":"Response to the Letter to the Editor by Caraway et al. on \u201cTissue Temperature Increases by a 10 kHz Spinal Cord Stimulation System: Phantom and Bioheat Model\u201d","volume":"22","author":"Khadka","year":"2019","journal-title":"Neuromodulation"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.clinph.2020.03.040","article-title":"Differences in EEG patterns between tonic and high frequency spinal cord stimulation in chronic pain patients","volume":"131","author":"Telkes","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.2147\/JPR.S160890","article-title":"Functional magnetic resonance imaging: Cerebral function alterations in subthreshold and suprathreshold spinal cord stimulation","volume":"11","author":"Sunaert","year":"2018","journal-title":"J. Pain Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/papr.12922","article-title":"A Regions of Interest Voxel-Based Morphometry Study of the Human Brain During High-Frequency Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome","volume":"20","author":"Goudman","year":"2020","journal-title":"Pain Pract."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1097\/j.pain.0000000000001854","article-title":"Spinal cord stimulation in chronic neuropathic pain: Mechanisms of action, new locations, new paradigms","volume":"161","author":"Joosten","year":"2020","journal-title":"Pain"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.pain.2012.08.011","article-title":"Peripheral nerve injury produces a sustained shift in the balance between glutamate release and uptake in the dorsal horn of the spinal cord","volume":"153","author":"Inquimbert","year":"2012","journal-title":"Pain"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.brainresbull.2020.09.005","article-title":"High-frequency spinal cord stimulation treatment attenuates the increase in spinal glutamate release and spinal miniature excitatory postsynaptic currents in rats with spared nerve injury-induced neuropathic pain","volume":"164","author":"Liao","year":"2020","journal-title":"Brain Res. Bull."},{"key":"ref_109","first-page":"331","article-title":"Paresthesia-Independence: An Assessment of Technical Factors Related to 10 kHz Paresthesia-Free Spinal Cord Stimulation","volume":"20","author":"Paroli","year":"2017","journal-title":"Pain Physician"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/pm\/pnx237","article-title":"Long-Term Improvements in Chronic Axial Low Back Pain Patients without Previous Spinal Surgery: A Cohort Analysis of 10-kHz High-Frequency Spinal Cord Stimulation over 36 Months","volume":"19","author":"Palmisani","year":"2018","journal-title":"Pain Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/pme.12294","article-title":"Sustained effectiveness of 10 kHz high-frequency spinal cord stimulation for patients with chronic, low back pain: 24-month results of a prospective multicenter study","volume":"15","author":"Smet","year":"2014","journal-title":"Pain Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1227\/NEU.0000000000001418","article-title":"Comparison of 10-kHz High-Frequency and Traditional Low-Frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: 24-Month Results From a Multicenter, Randomized, Controlled Pivotal Trial","volume":"79","author":"Kapural","year":"2016","journal-title":"Neurosurgery"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/5\/573\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:03:58Z","timestamp":1760162638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/5\/573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":112,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["biomedicines9050573"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9050573","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]}}}